Skip to main navigation Skip to search Skip to main content

Acute limb ischemia secondary to vaccine-induced thrombotic thrombocytopenia

  • Bowen Xie
  • , Dana B. Semaan
  • , Natalie D. Sridharan
  • , Mohammad H. Eslami
  • , Catherine Go

Research output: Contribution to journalArticlepeer-review

Abstract

Vaccine-associated thrombosis has previously been described in patients presenting with cerebral sinus thrombosis, deep venous thrombosis/pulmonary embolism, or mesenteric venous thrombosis. Only recently has arterial thrombosis gained attention. A new entity known as vaccine-induced thrombotic thrombocytopenia (VITT) has been associated with the coronavirus disease of 2019 (COVID-19) vaccines produced by AstraZeneca and Johnson & Johnson. We describe a case series of three patients who presented with acute limb ischemia with vaccine-associated arterial occlusions, one of whom was diagnosed with VITT.

Original languageEnglish (US)
Article number100153
JournalAnnals of Vascular Surgery - Brief Reports and Innovations
Volume3
Issue number1
DOIs
StatePublished - Mar 2023
Externally publishedYes

Keywords

  • Acute limb ischemia (ALI)
  • Vaccine-induced thrombotic thrombocytopenia (VITT)

ASJC Scopus subject areas

  • Surgery
  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Acute limb ischemia secondary to vaccine-induced thrombotic thrombocytopenia'. Together they form a unique fingerprint.

Cite this